MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 202 filers reported holding MYRIAD GENETICS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $98,875,000 | 3.47% |
| Tieton Capital Management, LLC | 187,636 | $3,711,000 | 2.72% |
| Glenview Capital Management | 3,682,691 | $72,825,000 | 1.67% |
| Altium Capital Management LP | 218,650 | $4,324,000 | 1.61% |
| S&T BANK/PA | 331,098 | $6,547,000 | 1.18% |
| EARNEST PARTNERS LLC | 6,731,429 | $133,114,000 | 0.92% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,078,075 | $41,094,000 | 0.79% |
| SummerHaven Investment Management, LLC | 35,700 | $706,000 | 0.55% |
| AIMZ Investment Advisors, LLC | 42,685 | $844,000 | 0.44% |
| CONTINENTAL ADVISORS LLC | 36,392 | $720,000 | 0.33% |